AUPH: Aurinia Pharmaceuticals Inc. Stock

by  •  • Comments Off on AUPH: Aurinia Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,008.07
Enterprise Value ($M) 924.67
Book Value ($M) 377.48
Book Value / Share 2.75
Price / Book 2.67
NCAV ($M) 273.43
NCAV / Share 1.99
Price / NCAV 3.69

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 4.17
Current Ratio 4.57

Balance Sheet (mrq) ($M)
Current Assets 446.60
Assets 550.64
Liabilities 173.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 235.13
Operating Income 12.52
Net Income 5.75

Cash Flow Statement (mra) ($M)
Cash From Operations 44.39
Cash from Investing 39.26
Cash from Financing -49.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-04 13D/A Tang Capital Management Llc 7.30 38.73
02-14 13G/A Armistice Capital, Llc 4.47 -21.95
2024-03-20 13D/A ILJIN SNT Co., Ltd. 5.20 4.96

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SE
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 127,827 1,241,700 10.29
2025-04-10 102,123 827,141 12.35
2025-04-09 424,727 2,100,946 20.22
2025-04-08 227,545 1,644,565 13.84
2025-04-07 206,281 2,024,466 10.19

(click for more detail)

Similar Companies
ARDX – Ardelyx, Inc. ATAI – Atai Life Sciences N.V.
ATXS – Astria Therapeutics, Inc. AURA – Aura Biosciences, Inc.
AVBP – ArriVent BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Aurinia Pharmaceuticals